CervoMed Inc.
CRVO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$16,291 | -$2,172 | -$5,803 | -$24,096 |
| Dep. & Amort. | $0 | $0 | $0 | $93 |
| Deferred Tax | $0 | $0 | $0 | -$444 |
| Stock-Based Comp. | $1,406 | $408 | $0 | $897 |
| Change in WC | -$441 | -$261 | $380 | $356 |
| Other Non-Cash | -$1,205 | -$5,424 | $2,850 | $8,691 |
| Operating Cash Flow | -$16,531 | -$7,450 | -$2,573 | -$14,502 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $4 |
| Inv. Purchases | -$48,101 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $19,440 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$28,661 | $0 | $0 | $4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $6,000 |
| Stock Issued | $46,399 | $810 | $0 | $31,094 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $10,339 | $0 | -$3,799 |
| Financing Cash Flow | $46,399 | $11,149 | $0 | $33,296 |
| Forex Effect | $0 | $0 | -$30,647 | $0 |
| Net Chg. in Cash | $1,207 | $3,699 | -$33,220 | $18,798 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,793 | $4,094 | $37,314 | $18,516 |
| End Cash | $8,999 | $7,793 | $4,094 | $37,314 |
| Free Cash Flow | -$16,531 | -$7,450 | -$2,573 | -$14,502 |